Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

α2-Adrenergic agonists including xylazine and dexmedetomidine inhibit norepinephrine transporter function in SK-N-SH cells.

Park JW, Chung HW, Lee EJ, Jung KH, Paik JY, Lee KH.

Neurosci Lett. 2013 Apr 29;541:184-9. doi: 10.1016/j.neulet.2013.02.022. Epub 2013 Feb 26.

PMID:
23485735
2.

Contribution of α2A-adrenoceptor subtype to effect of dexmedetomidine and xylazine on spinal synaptic transmission of mice.

Kobayashi T, Otsuguro K, Yamaguchi S, Ito S.

Eur J Pharmacol. 2015 Aug 15;761:321-9. doi: 10.1016/j.ejphar.2015.06.020. Epub 2015 Jun 16.

PMID:
26086861
4.

Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.

Apparsundaram S, Schroeter S, Giovanetti E, Blakely RD.

J Pharmacol Exp Ther. 1998 Nov;287(2):744-51.

5.

Effect of adrenergic receptor ligands on metaiodobenzylguanidine uptake and storage in neuroblastoma cells.

Babich JW, Graham W, Fischman AJ.

Eur J Nucl Med. 1997 May;24(5):538-43.

PMID:
9142735
7.

Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles.

Mandela P, Chandley M, Xu YY, Zhu MY, Ordway GA.

Neurochem Int. 2010 May-Jun;56(6-7):760-7. doi: 10.1016/j.neuint.2010.02.011. Epub 2010 Feb 20.

8.
9.

Pentazocine inhibits norepinephrine transporter function by reducing its surface expression in bovine adrenal medullary cells.

Obara G, Toyohira Y, Inagaki H, Takahashi K, Horishita T, Kawasaki T, Ueno S, Tsutsui M, Sata T, Yanagihara N.

J Pharmacol Sci. 2013;121(2):138-47. Epub 2013 Feb 1.

10.

Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by α2 adrenoceptor agonist dexmedetomidine.

Chiu KM, Lin TY, Lu CW, Wang SJ.

Eur J Pharmacol. 2011 Nov 16;670(1):137-47. doi: 10.1016/j.ejphar.2011.08.012. Epub 2011 Sep 2.

PMID:
21914443
11.

Low-dose dexmedetomidine facilitates the carotid body response to low oxygen tension in vitro via α2-adrenergic receptor activation in rabbits.

Nakatani H, Kim C, Sakamoto A.

Eur J Anaesthesiol. 2012 Dec;29(12):570-6. doi: 10.1097/EJA.0b013e328356fba5.

PMID:
22965459
12.

The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure.

Szpunar MJ, Burke KA, Dawes RP, Brown EB, Madden KS.

Cancer Prev Res (Phila). 2013 Dec;6(12):1262-72. doi: 10.1158/1940-6207.CAPR-13-0079.

13.

Effect of dexmedetomidine on the release of [3H]-noradrenaline from rat kidney cortex slices: characterization of alpha2-adrenoceptor.

Taoda M, Adachi YU, Uchihashi Y, Watanabe K, Satoh T, Vizi ES.

Neurochem Int. 2001 Apr;38(4):317-22.

PMID:
11137626
14.

Chronic activation of central alpha2-adrenoceptors prevents hypertension in DOCA-salt rats.

Cabral AM, da Silva IF, Gardioli CR, Menegaz RG.

Auton Neurosci. 2000 Aug 14;82(3):146-53.

PMID:
11023621
15.

Effects of anesthetic agents on cellular 123I-MIBG transport and in vivo 123I-MIBG biodistribution.

Ko BH, Paik JY, Jung KH, Bae JS, Lee EJ, Choe YS, Kim BT, Lee KH.

Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):554-61. Epub 2007 Oct 13.

PMID:
17934728
16.

Dexmedetomidine and clonidine inhibit the function of Na(v)1.7 independent of α(2)-adrenoceptor in adrenal chromaffin cells.

Maruta T, Nemoto T, Satoh S, Kanai T, Yanagita T, Wada A, Tsuneyoshi I.

J Anesth. 2011 Aug;25(4):549-57. doi: 10.1007/s00540-011-1168-6. Epub 2011 May 24.

PMID:
21607767
17.
18.

Comparison of the mechanical hypoalgesic effects of five α2-adrenoceptor agonists in donkeys.

Lizarraga I, Janovyak E.

Vet Rec. 2013 Sep 28;173(12):294. doi: 10.1136/vr.101684. Epub 2013 Jul 22.

PMID:
23878192
Items per page

Supplemental Content

Write to the Help Desk